Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | BLM | P54132 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | PPARG | P37231 | 1/20 | 0.54 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.54 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.54 |
| ▸ | FPR2 | P25090 | 4/20 | 0.43 |
| ▸ | TGM2 | P21980 | 1/20 | 0.43 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.38 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 2/20 | 0.37 |
| ▸ | CA9 | Q16790 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12216725 | 0.94 | MEN1 (0.55) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL16593584 | 0.94 | MEN1 (0.54) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL29349953 | 0.94 | MEN1 (0.54) | MEN1BLMKMT2AUSP2POLB | |
| Isothiocyanate SCHEMBL28202026 | 0.91 | MEN1 (0.52) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL21263759 | 0.88 | MEN1 (0.56) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL25596330 | 0.87 | MEN1 (0.45) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL13428252 | 0.85 | USP2 (0.59) | MEN1BLMKMT2AUSP2POLB | |
| Hydrochloric Acid SCHEMBL29370904 | 0.84 | MEN1 (0.51) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL14958553 | 0.84 | MEN1 (0.56) | MEN1BLMKMT2AUSP2POLB | |
| SCHEMBL3903552 | 0.84 | MEN1 (0.61) | MEN1BLMKMT2AUSP2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 752 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12498366-B2 | Measurement method for fibroblast growth factor-23 by forming immunocomplexes | CANON MEDICAL DIAGNOSTICS CORPORATION (JP) | 2025-12-16 | — | — | US | claimed |
| US-20250188523-A1 | MICROBE DETECTION METHOD USING FISH ANALYSIS | UNIST(ULSAN NATIONAL INSTITUTE OF SCIENCE AND TECHNOLOGY) (KR) | 2025-06-12 | — | — | US | claimed |
| US-12291583-B2 | Carrageenan derivative, probe for labelling macrophages, and method for preparing same | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2025-05-06 | — | — | US | claimed |
| US-20240173418-A1 | CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN | 2024-05-30 | — | — | US | claimed |
| CN-117210218-A | Ratio type fluorescent probe for detecting cyanide ions and preparation method and application thereof | 德清县浙工大莫干山研究院 | 2023-12-12 | — | — | CN | claimed |
| CN-117186873-A | Ratio type fluorescent probe for detecting thiocyanate ions and preparation method and application thereof | 浙江工业大学 | 2023-12-08 | — | — | CN | claimed |
| EP-3940000-B1 | CARRAGEENAN DERIVATIVE, PROBE FOR LABELLING MACROPHAGES, AND METHOD FOR PREPARING SAME | UNIV KOREA RES & BUS FOUND (KR) | 2023-11-22 | — | — | EP | claimed |
| CN-115331222-A | Machine reading method for circulating tumor cells | 江琴 | 2022-11-11 | — | — | CN | claimed |
| WO-2022204269-A1 | CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2022-09-29 | — | — | WO | claimed |
| US-20220162347-A1 | CARRAGEENAN DERIVATIVE, PROBE FOR LABELLING MACROPHAGES, AND METHOD FOR PREPARING SAME | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2022-05-26 | — | — | US | claimed |
| WO-2022102865-A1 | MICROBE DETECTION METHOD USING FISH ANALYSIS | 울산과학기술원 | 2022-05-19 | — | — | WO | claimed |
| US-11261475-B2 | Nano-neurotoxicity bio-marker composition based on intracellular aggregates which are biomarkers of degenerative brain diseases | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION | 2022-03-01 | — | — | US | claimed |
| US-20260147152-A1 | METHOD AND APPARATUS FOR FABRICATION OF LARGE THREE-DIMENSIONAL SINGLE COLLOIDAL CRYSTALS FOR BRAGG DIFFRACTION OF INFRARED LIGHT | NANORACKS, LLC (US) | 2026-05-28 | — | — | US | disclosed |
| CN-116036309-B | Layered double hydroxide material system and preparation method and application thereof | Shanghai Teyijie Biotechnology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122070480-A | Biomarker for diagnosis and prognosis prediction of diabetes-associated pancreatic cancer and application thereof | 延世大学校产学协力团 | 2026-05-19 | — | — | CN | disclosed |
| CN-122055621-A | Composition for diagnosing chronic rejection after kidney transplantation | 仁济大学校产学协力团 | 2026-05-15 | — | — | CN | disclosed |
| US-20220040105-A1 | NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME | MOOGENE MEDI CO., LTD. (KR) | 2022-02-10 | — | — | US | disclosed |
| US-11242564-B2 | Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes | INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) (FR) | 2022-02-08 | — | — | US | disclosed |
| CN-110198741-B | Composition for photodynamic therapy using gene expressing fluorescent protein and photosensitizer, and photodynamic therapy method using same | 株式会社科尔制药 | 2022-02-08 | — | — | CN | disclosed |
| US-11230736-B2 | Methods for assessing pregnancy outcome | INSERM (INSTITUT NATIONAL DE LA SANTÉ DE LA RECHERCHE MÉDICALE) (FR) | 2022-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240173418-A1 | CYCLIC DINUCLEOTIDE CONJUGATES AND RELATED METHODS OF USE THEREOF | DPYD, DUT, CD38 | MEN1 1063/4885BLM 367/4885KMT2A 3582/4885 |
| US-20260147152-A1 | METHOD AND APPARATUS FOR FABRICATION OF LARGE THREE-DIMENSIONAL SINGLE COLLOIDAL CRYSTALS FOR BRAGG DIFFRACTION OF INFRARED LIGHT | CTTN, CSPP1, NES | MEN1 2591/4885BLM 1562/4885KMT2A 2751/4885 |
| US-20220040105-A1 | NANOLIPOSOME-MICROBUBBLE CONJUGATE INCLUDING DRUG FOR HAIR LOSS TREATMENT ENCAPSULATED IN NANOLIPOSOME AND COMPOSITION FOR ALLEVIATING OR TREATING HAIR LOSS CONTAINING SAME | CYP11A1, SHH, AR | MEN1 449/4885BLM 4473/4885KMT2A 1428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.